CoChat
Sign Up
Cited by 346

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region

Wu, S, Huang, S, Ding, J, Zhao, Y, Liang, L, Liu, T, Zhan, R, He, X·2010·Oncogene
DOI 10.1038/onc.2010.34
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1038/onc.2010.34

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297. · DOI
  2. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766–770. · DOI · Paper page
  3. Bortolin-Cavaille ML, Dance M, Weber M, Cavaille J . (2009). C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res 37: 3464–3473. · DOI
  4. Gartel AL, Tyner AL . (1999). Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246: 280–289. · DOI
  5. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P et al. (2007). Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387–392. · DOI
  6. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG et al. (2009). CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis. Genes Chromosomes Cancer 48: 615–623. · DOI
  7. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . (1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816. · DOI · Paper page
  8. Hausser J, Berninger P, Rodak C, Jantscher Y, Wirth S, Zavolan M . (2009). MirZ: an integrated microRNA expression atlas and target prediction resource. Nucleic Acids Res 37: 266–W272. · DOI
  9. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Lowenberg B . (2008). MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111: 5078–5085. · DOI
  10. Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20. · DOI · Paper page
  11. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S et al. (2009). Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 114: e20–e26. · DOI
  12. Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S . (2008). Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-insertion/deletion polymorphism with type 2 diabetes. Biochem Biophys Res Commun 374: 101–105. · DOI
  13. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M . (2001). Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 61: 6234–6238.
  14. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272–286. · DOI
  15. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP . (1999). p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci USA 96: 9089–9094. · DOI
  16. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN . (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575–579. · DOI
  17. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169–1181. · DOI
  18. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI . (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588–2592. · DOI
  19. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . (1993). p21 is a universal inhibitor of cyclin kinases. Nature 366: 701–704. · DOI

Cited by

Sorted by citations

Metadata

Authors
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X.
Venue
Oncogene
Publisher
Springer Science and Business Media LLC
Published
2010-03-01
Volume
29
Issue
15
Pages
2302-2308
ISSN
  • 0950-9232
  • 1476-5594
DOI
10.1038/onc.2010.34
Cited by
346
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review